According to a iciness & Sulli...

According to a iciness & Sullivan analysis, producing recombinant proteins in transgenic plants may help confront growing demand for limited biopharmaceutical manufacturing capacity. frigidity & Sullivan reports that the necessary technologies are generally in place, but product disclosure the regulatory environment, and public perception must be addressed before commercial